Hodogaya Chemical (4112) · InitiativeFirst statedLatest M&A and Subsidiary Changes (2026-09-02): "Advanced"
Commencement of collaboration with Yuki Gosei Kogyo Co.,Ltd. and acquisition of shares
First written in FY2026. 1 of 2 entries say "Advanced", first in 2026-09-02. Latest entry: 2026-09-02.
2entries
1years
1from disclosures
How it moved
Same theme, other companies
Start of collaboration with 有機合成薬品工業株式会社 and acquisition of its sharesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- 2026-09-02AdvancedM&A and Subsidiary Changes
「Yuki Gosei Kogyo Co.,Ltd. ("YGK") has an advanced manufacturing and quality-control system based on GMP standards developed through its long-standing low-molecular-weight pharmaceutical manufacturing business, as well as knowledge and expertise in manufacturing nucleic acid-related compounds. We are also considering a future transition to a joint-venture structure between our Group and YGK.」
The collaboration was specified as making use of YGK's GMP manufacturing and quality-control systems and its expertise in nucleic acid-related compounds. A future joint-venture structure was also identified for consideration. - FY2026First statedAnnual report
「February 2026 Collaboration with 有機合成薬品工業株式会社 began and shares were acquired.」
The start of collaboration with 有機合成薬品工業株式会社 and the acquisition of shares were first recorded in the corporate history.